Death of neuronal clusters contributes to variance of age at onset in Huntington's disease

被引:6
作者
Cajavec, B [1 ]
Herzel, H [1 ]
Bernard, S [1 ]
机构
[1] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany
关键词
one-hit model; stochastic process; neuron death; polyglutamine repeat; age of onset;
D O I
10.1007/s10048-005-0025-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded polyglutamine (polyQ) repeat in the protein huntingtin. Due to selective neuronal loss in the cortex and striatum, HD patients develop various movement disturbances, psychological changes, and dementia. Symptoms usually appear in individuals between 30 and 50 years of age. The principal cause of variability of age at onset (AO) is the length of the polyQ repeat. Several additional genetic factors contributing to the variance have been identified. At least 35% of the variance, however, remains unexplained. Using a stochastic model, we show that the pattern of cell death of striatal neurons might contribute up to 20% of variance of AO.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 27 条
  • [1] Different phenotypic expression in monozygotic twins with Huntington disease
    Anca, MH
    Gazit, E
    Loewenthal, R
    Ostrovsky, O
    Frydman, M
    Giladi, N
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 124A (01): : 89 - 91
  • [2] THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE
    ANDREW, SE
    GOLDBERG, YP
    KREMER, B
    TELENIUS, H
    THEILMANN, J
    ADAM, S
    STARR, E
    SQUITIERI, F
    LIN, BY
    KALCHMAN, MA
    GRAHAM, RK
    HAYDEN, MR
    [J]. NATURE GENETICS, 1993, 4 (04) : 398 - 403
  • [3] Huntington's disease progression PET and clinical observations
    Andrews, TC
    Weeks, RA
    Turjanski, N
    Gunn, RN
    Watkins, LHA
    Sahakian, B
    Hodges, JR
    Rosser, AE
    Wood, NW
    Brooks, DJ
    [J]. BRAIN, 1999, 122 : 2353 - 2363
  • [4] NR2A and NR2B receptor gene variations modify age at onset in Huntington disease
    Arning, L
    Kraus, PH
    Valentin, S
    Saft, C
    Andrich, J
    Epplen, JT
    [J]. NEUROGENETICS, 2005, 6 (01) : 25 - 28
  • [5] Dopamine D-1 and D-2 receptor gene expression in the striatum in Huntington's disease
    Augood, SJ
    Faull, RLM
    Emson, PC
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (02) : 215 - 221
  • [6] Onset and rate of striatal atrophy in preclinical Huntington disease
    Aylward, EH
    Sparks, BF
    Field, KM
    Yallapragada, V
    Shpritz, BD
    Rosenblatt, A
    Brandt, J
    Gourley, LM
    Liang, K
    Zhou, H
    Margolis, RL
    Ross, CA
    [J]. NEUROLOGY, 2004, 63 (01) : 66 - 72
  • [7] Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes
    Chattopadhyay, B
    Baksi, K
    Mukhopadhyay, S
    Bhattacharyya, NP
    [J]. NEUROSCIENCE LETTERS, 2005, 374 (02) : 81 - 86
  • [8] A one-hit model of cell death in inherited neuronal degenerations
    Clarke, G
    Collins, RA
    Leavitt, BR
    Andrews, DF
    Hayden, MR
    Lumsden, CJ
    McInnes, RR
    [J]. NATURE, 2000, 406 (6792) : 195 - 199
  • [9] EARLY LOSS OF NEOSTRIATAL STRIOSOME NEURONS IN HUNTINGTONS-DISEASE
    HEDREEN, JC
    FOLSTEIN, SE
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01) : 105 - 120
  • [10] CORTICAL AND STRIATAL NEURON NUMBER IN HUNTINGTONS-DISEASE
    HEINSEN, H
    STRIK, M
    BAUER, M
    LUTHER, K
    ULMAR, G
    GANGNUS, D
    JUNGKUNZ, G
    EISENMENGER, W
    GOTZ, M
    [J]. ACTA NEUROPATHOLOGICA, 1994, 88 (04) : 320 - 333